Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis

Abstract Background Exosomes are nanoscale membrane vesicles secreted by both normal and cancer cells, and cancer cell-derived exosomes play an important role in the cross-talk between cancer cells and other cellular components in the tumor microenvironment. Mesenchymal stem cells (MSCs) have tropis...

Full description

Bibliographic Details
Main Authors: Zhanjun Ma, Xue Cui, Li Lu, Guohu Chen, Yang Yang, Yan Hu, Yubao Lu, Zhangqi Cao, Yan Wang, Xuexi Wang
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-019-1149-5
_version_ 1828962488379506688
author Zhanjun Ma
Xue Cui
Li Lu
Guohu Chen
Yang Yang
Yan Hu
Yubao Lu
Zhangqi Cao
Yan Wang
Xuexi Wang
author_facet Zhanjun Ma
Xue Cui
Li Lu
Guohu Chen
Yang Yang
Yan Hu
Yubao Lu
Zhangqi Cao
Yan Wang
Xuexi Wang
author_sort Zhanjun Ma
collection DOAJ
description Abstract Background Exosomes are nanoscale membrane vesicles secreted by both normal and cancer cells, and cancer cell-derived exosomes play an important role in the cross-talk between cancer cells and other cellular components in the tumor microenvironment. Mesenchymal stem cells (MSCs) have tropism for tumors and have been used as tumor-tropic vectors for tumor therapy; however, the safety of such therapeutic use of MSCs is unknown. In this study, we investigated the role of glioma cell-derived exosomes in the tumor-like phenotype transformation of human bone marrow mesenchymal stem cells (hBMSCs) and explored the underlying molecular mechanisms. Methods The effect of exosomes from U251 glioma cells on the growth of hBMSCs was evaluated with the CCK-8 assay, KI67 staining, and a cell cycle distribution assessment. The migration and invasion of hBMSCs were evaluated with a Transwell assay. A proteomics and bioinformatics approach, together with Western blotting and reverse transcriptase-polymerase chain reaction, was used to investigate the effect of U251 cell-derived exosomes on the proteome of hBMSCs. Results U251 cell-derived exosomes induced a tumor-like phenotype in hBMSCs by enhancing their proliferation, migration, and invasion and altering the production of proteins involved in the regulation of the cell cycle. Moreover, U251 cell-derived exosomes promoted the production of the metastasis-related proteins MMP-2 and MMP-9, glioma marker GFAP, and CSC markers (CD133 and Nestin). The ten differentially expressed proteins identified participated in several biological processes and exhibited various molecular functions, mainly related to the inactivation of glycolysis. Western blotting showed that U251 cell-derived exosomes upregulated the levels of Glut-1, HK-2, and PKM-2, leading to the induction of glucose consumption and generation of lactate and ATP. Treatment with 2-deoxy-d-glucose significantly reversed these effects of U251 cell-derived exosomes on hBMSCs. Conclusions Our data demonstrate that glioma cell-derived exosomes activate glycolysis in hBMSCs, resulting in their tumor-like phenotype transformation. This suggests that interfering with the interaction between exosomes and hBMSCs in the tumor microenvironment has potential as a therapeutic approach for glioma. Graphical abstract ᅟ
first_indexed 2024-12-14T10:05:01Z
format Article
id doaj.art-01582213e6984f9a997bd97d27be425c
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-14T10:05:01Z
publishDate 2019-02-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-01582213e6984f9a997bd97d27be425c2022-12-21T23:07:09ZengBMCStem Cell Research & Therapy1757-65122019-02-0110111810.1186/s13287-019-1149-5Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysisZhanjun Ma0Xue Cui1Li Lu2Guohu Chen3Yang Yang4Yan Hu5Yubao Lu6Zhangqi Cao7Yan Wang8Xuexi Wang9The Second Clinical Medical College, Lanzhou UniversityThe First Clinical Medical College, Lanzhou UniversityInstitute of Pharmacology, School of Basic Medical Science, Lanzhou UniversityThe First Clinical Medical College, Lanzhou UniversityThe Second Clinical Medical College, Lanzhou UniversitySchool of Basic Medical Sciences, Lanzhou UniversityThe Second Clinical Medical College, Lanzhou UniversitySchool of Basic Medical Sciences, Lanzhou UniversitySchool of Basic Medical Sciences, Lanzhou UniversitySchool of Basic Medical Sciences, Lanzhou UniversityAbstract Background Exosomes are nanoscale membrane vesicles secreted by both normal and cancer cells, and cancer cell-derived exosomes play an important role in the cross-talk between cancer cells and other cellular components in the tumor microenvironment. Mesenchymal stem cells (MSCs) have tropism for tumors and have been used as tumor-tropic vectors for tumor therapy; however, the safety of such therapeutic use of MSCs is unknown. In this study, we investigated the role of glioma cell-derived exosomes in the tumor-like phenotype transformation of human bone marrow mesenchymal stem cells (hBMSCs) and explored the underlying molecular mechanisms. Methods The effect of exosomes from U251 glioma cells on the growth of hBMSCs was evaluated with the CCK-8 assay, KI67 staining, and a cell cycle distribution assessment. The migration and invasion of hBMSCs were evaluated with a Transwell assay. A proteomics and bioinformatics approach, together with Western blotting and reverse transcriptase-polymerase chain reaction, was used to investigate the effect of U251 cell-derived exosomes on the proteome of hBMSCs. Results U251 cell-derived exosomes induced a tumor-like phenotype in hBMSCs by enhancing their proliferation, migration, and invasion and altering the production of proteins involved in the regulation of the cell cycle. Moreover, U251 cell-derived exosomes promoted the production of the metastasis-related proteins MMP-2 and MMP-9, glioma marker GFAP, and CSC markers (CD133 and Nestin). The ten differentially expressed proteins identified participated in several biological processes and exhibited various molecular functions, mainly related to the inactivation of glycolysis. Western blotting showed that U251 cell-derived exosomes upregulated the levels of Glut-1, HK-2, and PKM-2, leading to the induction of glucose consumption and generation of lactate and ATP. Treatment with 2-deoxy-d-glucose significantly reversed these effects of U251 cell-derived exosomes on hBMSCs. Conclusions Our data demonstrate that glioma cell-derived exosomes activate glycolysis in hBMSCs, resulting in their tumor-like phenotype transformation. This suggests that interfering with the interaction between exosomes and hBMSCs in the tumor microenvironment has potential as a therapeutic approach for glioma. Graphical abstract ᅟhttp://link.springer.com/article/10.1186/s13287-019-1149-5ExosomesGlioma cellsGlycolytic pathwayTumor-like phenotype transformationMesenchymal stem cellsProteomics
spellingShingle Zhanjun Ma
Xue Cui
Li Lu
Guohu Chen
Yang Yang
Yan Hu
Yubao Lu
Zhangqi Cao
Yan Wang
Xuexi Wang
Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis
Stem Cell Research & Therapy
Exosomes
Glioma cells
Glycolytic pathway
Tumor-like phenotype transformation
Mesenchymal stem cells
Proteomics
title Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis
title_full Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis
title_fullStr Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis
title_full_unstemmed Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis
title_short Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis
title_sort exosomes from glioma cells induce a tumor like phenotype in mesenchymal stem cells by activating glycolysis
topic Exosomes
Glioma cells
Glycolytic pathway
Tumor-like phenotype transformation
Mesenchymal stem cells
Proteomics
url http://link.springer.com/article/10.1186/s13287-019-1149-5
work_keys_str_mv AT zhanjunma exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT xuecui exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT lilu exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT guohuchen exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT yangyang exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT yanhu exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT yubaolu exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT zhangqicao exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT yanwang exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis
AT xuexiwang exosomesfromgliomacellsinduceatumorlikephenotypeinmesenchymalstemcellsbyactivatingglycolysis